View in EDS

A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.

Saved in:
Bibliographic Details
Title: A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.
Authors: Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan. takuya.tsujino@ompu.ac.jp.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan. takuya.tsujino@ompu.ac.jp., Yamazaki S; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Sakamoto M; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan., Yoshikawa Y; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan., Nakajima Y; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Hirosuna K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan., Takai T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan.; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ishida M; Department of Pathology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nakamura K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Iwatsuki K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tsuchida S; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Matsuda T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Higashio T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Fukushima T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nishio K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nakamori K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tsutsumi T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Matsunaga T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Taniguchi K; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan., Shimbo T; Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Tanaka T; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan., Takahara K; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan., Inamoto T; Department of Urology, Hamamatsu University School of Medicine, Shizuoka, Japan., Hirose Y; Department of Pathology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Ono F; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan., Yamamoto K; Department of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Nihei K; Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Osuga K; Department of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Osaka, Japan., Jia L; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kibel AS; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan. k.komura@med.kawasaki-m.ac.jp.; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan. k.komura@med.kawasaki-m.ac.jp.; Department of Urology, Kawasaki Medical School, Okayama, Japan. k.komura@med.kawasaki-m.ac.jp., Yoshimi A; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan. ayoshimi@ncc.go.jp., Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 Jul 02; Vol. 11 (1). Date of Electronic Publication: 2026 Jul 02.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42469227
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tsujino+T%22">Tsujino T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan. takuya.tsujino@ompu.ac.jp.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan. takuya.tsujino@ompu.ac.jp.<br /><searchLink fieldCode="AU" term="%22Yamazaki+S%22">Yamazaki S</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Sakamoto+M%22">Sakamoto M</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshikawa+Y%22">Yoshikawa Y</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Maenosono+R%22">Maenosono R</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nakajima+Y%22">Nakajima Y</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Hirosuna+K%22">Hirosuna K</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takai+T%22">Takai T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nishimura+K%22">Nishimura K</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan.; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ishida+M%22">Ishida M</searchLink>; Department of Pathology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamura+K%22">Nakamura K</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Iwatsuki+K%22">Iwatsuki K</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuchida+S%22">Tsuchida S</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Matsuda+T%22">Matsuda T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Higashio+T%22">Higashio T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Fukushima+T%22">Fukushima T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nishio+K%22">Nishio K</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nakamori+K%22">Nakamori K</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tsutsumi+T%22">Tsutsumi T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Matsunaga+T%22">Matsunaga T</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Taniguchi+K%22">Taniguchi K</searchLink>; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Shimbo+T%22">Shimbo T</searchLink>; Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tanaka+T%22">Tanaka T</searchLink>; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Takahara+K%22">Takahara K</searchLink>; Department of Urology, Fujita-Health University School of Medicine, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Inamoto+T%22">Inamoto T</searchLink>; Department of Urology, Hamamatsu University School of Medicine, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Hirose+Y%22">Hirose Y</searchLink>; Department of Pathology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Ono+F%22">Ono F</searchLink>; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+K%22">Yamamoto K</searchLink>; Department of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nihei+K%22">Nihei K</searchLink>; Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Osuga+K%22">Osuga K</searchLink>; Department of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Jia+L%22">Jia L</searchLink>; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kibel+AS%22">Kibel AS</searchLink>; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Komura+K%22">Komura K</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan. k.komura@med.kawasaki-m.ac.jp.; Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Osaka, Japan. k.komura@med.kawasaki-m.ac.jp.; Department of Urology, Kawasaki Medical School, Okayama, Japan. k.komura@med.kawasaki-m.ac.jp.<br /><searchLink fieldCode="AU" term="%22Yoshimi+A%22">Yoshimi A</searchLink>; Division of Cancer RNA Research, National Cancer Center Research Institute, Tokyo, Japan. ayoshimi@ncc.go.jp.<br /><searchLink fieldCode="AU" term="%22Azuma+H%22">Azuma H</searchLink>; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101676423%22">Signal transduction and targeted therapy</searchLink> [Signal Transduct Target Ther] 2026 Jul 02; Vol. 11 (1). <i>Date of Electronic Publication: </i>2026 Jul 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101676423 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-3635 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220593635%22">20593635 </searchLink><i>NLM ISO Abbreviation: </i>Signal Transduct Target Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42469227
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41392-026-02847-6
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tsujino T
      – PersonEntity:
          Name:
            NameFull: Yamazaki S
      – PersonEntity:
          Name:
            NameFull: Sakamoto M
      – PersonEntity:
          Name:
            NameFull: Yoshikawa Y
      – PersonEntity:
          Name:
            NameFull: Maenosono R
      – PersonEntity:
          Name:
            NameFull: Nakajima Y
      – PersonEntity:
          Name:
            NameFull: Hirosuna K
      – PersonEntity:
          Name:
            NameFull: Takai T
      – PersonEntity:
          Name:
            NameFull: Nishimura K
      – PersonEntity:
          Name:
            NameFull: Ishida M
      – PersonEntity:
          Name:
            NameFull: Nakamura K
      – PersonEntity:
          Name:
            NameFull: Iwatsuki K
      – PersonEntity:
          Name:
            NameFull: Tsuchida S
      – PersonEntity:
          Name:
            NameFull: Matsuda T
      – PersonEntity:
          Name:
            NameFull: Higashio T
      – PersonEntity:
          Name:
            NameFull: Fukushima T
      – PersonEntity:
          Name:
            NameFull: Nishio K
      – PersonEntity:
          Name:
            NameFull: Nakamori K
      – PersonEntity:
          Name:
            NameFull: Tsutsumi T
      – PersonEntity:
          Name:
            NameFull: Matsunaga T
      – PersonEntity:
          Name:
            NameFull: Taniguchi K
      – PersonEntity:
          Name:
            NameFull: Shimbo T
      – PersonEntity:
          Name:
            NameFull: Tanaka T
      – PersonEntity:
          Name:
            NameFull: Takahara K
      – PersonEntity:
          Name:
            NameFull: Inamoto T
      – PersonEntity:
          Name:
            NameFull: Hirose Y
      – PersonEntity:
          Name:
            NameFull: Ono F
      – PersonEntity:
          Name:
            NameFull: Yamamoto K
      – PersonEntity:
          Name:
            NameFull: Nihei K
      – PersonEntity:
          Name:
            NameFull: Osuga K
      – PersonEntity:
          Name:
            NameFull: Jia L
      – PersonEntity:
          Name:
            NameFull: Kibel AS
      – PersonEntity:
          Name:
            NameFull: Komura K
      – PersonEntity:
          Name:
            NameFull: Yoshimi A
      – PersonEntity:
          Name:
            NameFull: Azuma H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 07
              Text: 2026 Jul 02
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2059-3635
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Signal transduction and targeted therapy
              Type: main
ResultId 1